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Abstract
Background: The aim of this study was to investigate whether pericardial effusion (PE)
detected by transthoracic echocardiography (TTE) was clinically significant and whether rou-
tine echocardiography was necessary after catheter ablation of atrioventricular nodal re-en-
trant tachycardia (AVNRT).
Methods: A total of 202 patients with AVNRT were included in the study from three centers.
The patients received basic electrophysiology-guided therapy, followed by radiofrequency abla-
tion (RFA). All patients underwent TTE before and after RFA therapy.
Results: The mean age of the study population was 46.2 ± 17.9 and 30.7% of the patients
were male. Of these patients, six (3%) had postoperative PE, as detected by TTE. However,
none of them had cardiac tamponade (CT). Four patients had minimal PE, while two had
mild PE. Repeated TTE at one to three months showed resolved PE. No significant difference
was seen among the patients with and/or without PE in terms of age, gender, the number of
RFA applications, or RFA duration; however, significantly prolonged duration of fluoroscopy
exposure was observed in the patients with PE.
Conclusions: PE was detected in 3% of the patients by TTE and associated with prolonged
duration of fluoroscopy exposure. However, no patients with moderate or large PE or cardiac
tamponade were found in the study. In conclusion, we suggest that TTE should only be
performed in the presence of clinical indications following ablation of AVNRT. (Cardiol J
2012; 19, 3: 274–277)
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Introduction
Radiofrequency catheter ablation (RFA) has
become the first-line therapy for atrioventricular
nodal re-entrant tachycardia (AVNRT) [1–3].
The incidence of pericardial effusion (PE) and
cardiac tamponade (CT) following radiofrequency
ablation (RFA) of AVNRT have been found to be
quite low [4–9], and the American College of Car-
diology (ACC)/American Heart Association (AHA)
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guidelines do not state that it is necessary to per-
form echocardiography to detect these complica-
tions [10]. The incidence of PE has been underes-
timated in many studies, since transthoracic
echocardiography (TTE) has been performed in
cases of the presence of clinical indications. There
is very limited evidence on the incidence and clini-
cal significance of PE following RFA therapy.
In this study, we investigated whether the in-
cidence of PE or CT detected by TTE is clinically
significant and whether routine echocardiography
is necessary after catheter ablation of AVNRT.
Methods
Patient population
Between January 2007 and May 2011, a total
of 202 patients who were scheduled to undergo RFA
of AVNRT were included in this prospective study
conducted in three centers (Hospital A, Hospital B,
and Hospital C). Electrophysiology study (EPS) and
RFA were performed using three operators.
All patients who underwent RFA had TTE per-
formed before the procedure and again in the first
24 h after the procedure. PE was graded on the basis
of the effusion thickness measured during diastole
in the parasternal short-axis images. Accordingly,
< 1 mm was considered as minimal, 1–10 mm was
mild, 10–20 mm was moderate, and > 20 mm was
large. CT was defined as moderate or large when
concomitant hemodynamic compromise was found
with PE. The study was reviewed and approved by
the local Ethics Committee.
Electrophysiology study and RFA therapy
EPS was performed by placing a quadripolar
catheter at the right ventricular apex and His bun-
dle and a decapolar catheter at the coronary sinus
via femoral veins. Drugs preceding EPS were di-
scontinued before at least five half-lives. The basic
electrophysiological measurements were perfor-
med and AVNRT was induced in accordance with
the predefined protocols.
Ablation procedure was performed using
a 4-mm tip ablation catheter and giving RF energy
at a low voltage. RFA was performed using the pre-
defined mapping and ablation techniques. The RF
energy was delivered with a power typically to
achieve a temperature of 50–65°C. Considering in-
tracardiac electrographic and fluoroscopic findings,
the RF energy was applied to appropriate sites for
between 30 s and 2 min. The procedure was termi-
nated in cases of the absence of junctional rhythm
within the first 10 s, occurrence of fast junctional
tachycardia with cycle lengths below 350 ms, oc-
currence of ventriculoatrial or atrioventricular
block, or excessive increase of impedance. RFA pro-
cedure was performed by an antegrade approach
from the femoral vein through the posteroseptal area
of the tricuspid annulus.
Statistical analysis
Normally distributed numeric variables were
expressed in mean ± standard deviation, whereas
non-normally distributed numeric variables were
expressed in median, and categorical variables were
expressed in percentage. A p value of < 0.05 was
considered statistically significant. Student’s t-test
was used for normally distributed numeric variables
in the intergroup analysis, Mann-Whitney U test was
used for non-normally distributed numeric variables,
and c2 test was used for categorical variables in the
intergroup analysis. Statistical analysis was per-
formed using SPSS v.15.0 (Statistical Package for
Social Science; SPSS Inc., Chicago, IL, USA).
Results
A total of 202 patients with AVNRT were inclu-
ded. The mean age was 46.2 ± 17.9 years and 30.7%
of the patients were male. Of these patients, TTE
showed minimal PE only in one patient before cath-
eter ablation. Six (3%) had PE as detected by TTE,
but none of them had CT after catheter ablation. Four
patients had minimal PE, while two had mild PE. No
moderate or severe PE was detected. These patients
were asymptomatic and were scheduled for follow
up. Control TTE at 1–3 months showed resolved PE.
No difference was seen among patients with and
without PE in terms of age, gender, the number of
RFA applications, or RFA duration; however, signi-
ficantly prolonged duration of fluoroscopy exposure
was observed in patients with PE (Table 1).
Discussion
Our study revealed that the incidence of PE
was very low (3%) following RFA of AVNRT and
also that there was no hemodynamically relevant
PE or CT. We also demonstrated that fluoroscopy
duration is an important factor for the development
of PE after RFA therapy, although the number of
RFA applications and RFA duration were not. Based
on these results, we suggest that routine echocar-
diography is not necessary after RFA of AVNRT
patients, but in the presence of clinical or hemody-
namic doubt, or prolonged fluoroscopy exposure for
various reasons, it would be appropriate.
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RFA for patients with AVNRT is a highly ef-
fective treatment option (> 98%) and has started
to become the first-line therapy. It is a safe method
for acute periods while having a very low complica-
tion rate [11–13], PE, which is one of the minor
complications, may develop after RFA of AVNRT
as well as RFA of accessory pathway, atrial flutter
and atrial fibrillation [8]. However, there is limited
evidence on the incidence and clinical significance
of PE following RFA therapy. In our study, we found
the incidence of PE to be 3%. Many studies have
reported the incidence of PE to be between 0.2%
and 4% (Table 2). However, this is not the actual
rate. There are several reasons why the actual in-
cidence rate is underestimated. The most impor-
tant reason is that TTE was not performed routine-
ly, or only performed after RFA for clinically indi-
cated situations, in most of the large, prospective
studies related to AVNRT. The second reason is
that the actual incidence rate might have been un-
derestimated in retrospective studies due to miss-
ing data or selection bias. The third reason is that
there is no consensus on the definition of PE de-
tected by TTE.
In this study, we graded PE as minimal, small,
moderate or large. Similarly, Schaer et al. graded
PE as small, moderate or large [8]. Pires et al. [9]
reported small PE in their study; however types of
PE were not reported in other studies. In our study,
the incidence of PE was 3%. However, if minimal
PEs were excluded, the incidence would be 1%.
There are some reports on PE following RFA
of supraventricular arrhythmias. In a prospective
study in which 966 patients underwent TTE follow-
ing RFA of AVNRT, AVRT or AV junction, Calkins
et al. [14] found the incidence of CT, PE, and peri-
carditis to be 0.6%, 1.9% and 0.38%, respectively.
This prospective study did not provide any sepa-
rate analysis for arrhythmia types. The higher in-
cidence of PE and CT was mostly reported in pa-
tients with supraventricular arrhythmia who under-
went RFA of atrial fibrillation [15]. The incidence
of PE was 1–13%, while the incidence of CT was
< 1%, following RFA of atrial fibrillation [8, 16, 17].
Transseptal puncture can also result in develop-
ment of a transmural lesion, and excessive mani-
pulation of the catheter positioned in the left atrium
may increase the incidence of PE.
The reason of non-hemodynamically significant
PE following RFA of AVNRT may be explained by
several mechanisms. We believe the primary me-
chanism is the excessive intracardiac catheter
manipulation and duration of the procedure or fluo-
roscopy. Prolonged catheter manipulation leading
Table 2. Frequency of pericardial effusion and cardiac tamponade in patients undergoing slow pathway
ablation*.
Study Age No. of patients Study PE [%] and no. Type of PE Tamponade [%]
Schaer et al. [8] 55 ± 16 184 R 2.1%: 4 pts 4 small 0
Kihel et al. [4] 56 ± 17 276 P 0.4%: 1 pt Not specified 1
Hoffman et al. [6] ? 3234 P 0.2%: 7 pts Not specified 1
Haghjoo et al. [7] 49 ± 14 268 R 0.7%: 2 pts Not specified 0
Kammeraad et al. [5] 1–19 years 65 R 1.5%: 1 pt Not specified 0
Pires et al. [9] ? 120 P 4.1%: 5 pts 5 small 0
Present study 46 ± 17 202 P 3.0%: 6 pts 4 minimal, 2 small 0
*Studies performed by routine echocardiography before and after catheter ablation were included; PE — pericardial effusion; P/R — prospective/
/retrospective studies
Table 1. Comparison of clinical and procedural characteristics according to the presence and absence
of pericardial effusion.
Variables Effusion present (n = 6) Effusion absent (n = 196) P
Age [years] 45 ± 20 46 ± 17 0.95
Sex (male/female) 1/5 61/135 0.45
Radiofrequency duration [s] 129 ± 42 117 ± 51 0.54
Radiofrequency application no. (median) 3.5 3.5 0.35
Fluoroscopy duration [min] 78 ± 24 53 ± 17 0.01
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to mechanical tissue trauma and effusion is a cause
of prolonged fluoroscopy.
In our study, the number of RFA applications
and total RFA duration were not associated with PE,
suggesting that lesion formation following RFA pro-
cedure might not be associated with the develop-
ment of effusion. Pires et al. [9] found that the num-
ber of RFA procedures was not associated with the
development of PE.
Conclusions
The incidence of pericardial effusion after RFA
of AVNRT was very low and there was no hemody-
namically relevant effusion or tamponade. Accor-
dingly, instead of performing routine echocardio-
graphy, it should be considered only in clinically
indicated conditions following RFA treatment.
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